Comparison of the performance of HPV DNA chip test and HPV PCR test in cervical cancer screening in rural China

Comparison of the performance of HPV DNA chip test and HPV PCR test in cervical cancer screening in rural China

BackgroundThis study aimed to evaluate the performance of two different principles of HPV testing in primary cervical cancer screening and ASC-US triage in rural areas.Methods3,328 and 3,913 women were enrolled in Shanxi, China in 2017 and 2018, respectively, and screened using liquid-based cytology...

Full description

Bibliographic Details
Main Authors:	Zhi-Fang Li, Xin-Hua Jia, Xin-Yu Ren, Bei-Ke Wu, Wen Chen, Xiang-Xian Feng, Li-Bing Wang, You-Lin Qiao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-11-01
Series:	Frontiers in Microbiology
Subjects:	human papillomavirus cervical cancer HPV DNA chip test HPV PCR test screening
Online Access:	https://www.frontiersin.org/articles/10.3389/fmicb.2022.1040285/full

Similar Items

Methodologies of Primary HPV Testing Currently Applied for Cervical Cancer Screening
by: Andreas C. Chrysostomou, et al.
Published: (2020-11-01)

Evaluation of the SureX HPV genotyping test for the detection of high-risk HPV in cervical cancer screening
by: Baojun Wei, et al.
Published: (2020-11-01)

Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples
by: Alice Avian, et al.
Published: (2022-05-01)

Quality assurance of human papillomavirus (HPV) testing in the implementation of HPV primary screening in Norway: an inter-laboratory reproducibility study
by: Birgit Engesæter, et al.
Published: (2016-11-01)

Comparison of HPV testing and cervical cytology in prevention of cervical cancer
by: Klaudia Remjasz, et al.
Published: (2022-08-01)

Comparison of HPV testing and cervical cytology in prevention of cervical cancer
by: Klaudia Remjasz, et al.
Published: (2022-08-01)

Development and validation of the cervical cancer knowledge scale and HPV testing knowledge scale in a sample of Canadian women
by: Ben Haward, et al.
Published: (2022-12-01)

HPV-Negative Cervical Cancer: A Narrative Review
by: Francesca Arezzo, et al.
Published: (2021-05-01)

High-risk HPV test in cervical cancer prevention – present and future
by: Natalia Zarankiewicz, et al.
Published: (2020-09-01)

Updates on HPV Vaccination
by: Ojone Illah, et al.
Published: (2023-01-01)

HPV virus as the main cause of cervical cancer, vaccination - literature review
by: Michał Paluch, et al.
Published: (2023-02-01)

CIN2+ detection of the HPV DNA Array genotyping assay in comparison with the Cobas 4800 HPV test and cytology
by: Aleksandra Pesic, et al.
Published: (2019-07-01)

Implications of Persistent HPV52 and HPV58 Positivity for the Management of Cervical Lesions
by: Baozhu Yi, et al.
Published: (2022-05-01)

Knowledge of cervical cancer, human papillomavirus (HPV), and acceptance of the HPV vaccine among parents of daughters in Riyadh, Saudi Arabia
by: Fatemah A. Alherz, et al.
Published: (2024-05-01)

Secondary school girls' knowledge and practice on human papillomavirus (HPV), cervical cancer and human papillomavirus (HPV) vaccination in Kuantan, Pahang, Malaysia
by: Khin Thandar Aung, et al.
Published: (2017-01-01)

HPV infection in cervical and other cancers in Saudi Arabia: implication for prevention and vaccination
by: Ghazi eAlsbeih
Published: (2014-03-01)

HPV and Cytology Testing in Women Undergoing 9-Valent HPV Opportunistic Vaccination: A Single-Cohort Follow Up Study
by: Rosa De Vincenzo, et al.
Published: (2021-06-01)

Is It Time to Genotype Beyond HPV16 and HPV18 for Cervical Cancer Screening?
by: Brandon Wen Bing Chua, et al.
Published: (2022-05-01)

Willingness to Self-Collect a Sample for HPV-Based Cervical Cancer Screening in a Well-Screened Cohort: HPV FOCAL Survey Results
by: Anne Lesack, et al.
Published: (2022-05-01)

Can HPV Test on Random Urine Replace Self-HPV Test on Vaginal Self-Samples or Clinician-Collected Cervical Samples?
by: Shih YH, et al.
Published: (2023-09-01)

Parents’ Knowledge and Attitude towards HPV and HPV Vaccination in Poland
by: Katarzyna Smolarczyk, et al.
Published: (2022-02-01)

Accuracy of Human Papillomavirus (HPV) Testing on Urine and Vaginal Self-Samples Compared to Clinician-Collected Cervical Sample in Women Referred to Colposcopy
by: Marianna Martinelli, et al.
Published: (2023-09-01)

Understanding the Challenges of HPV-Based Cervical Screening: Development and Validation of HPV Testing and Self-Sampling Attitudes and Beliefs Scales
by: Ovidiu Tatar, et al.
Published: (2023-01-01)

Relationship between awareness of cervical cancer and HPV infection and attitudes towards HPV vaccine among women aged 15-49 years: a cross-sectional study
by: Engin Yurtçu, et al.
Published: (2022-04-01)

HPV AND CERVICAL CANCER PREVENTION
by: Marjetka Uršič-Vrščaj, et al.
Published: (2018-02-01)

Prevalence of HPV and Assessing Type-Specific HPV Testing in Cervical High-Grade Squamous Intraepithelial Lesions in Poland
by: Marcin Przybylski, et al.
Published: (2023-02-01)

Performance of cervical cytology and HPV testing for primary cervical cancer screening in Latin America: an analysis within the ESTAMPA studyResearch in context
by: Arianis Tatiana Ramírez, et al.
Published: (2023-10-01)

HPV 18 variants in women with cervical cancer in Northeast Brazil
by: Gerusinete Rodrigues Bastos dos Santos, et al.
Published: (2023-01-01)

The Potential Benefits of HPV E6/E7 mRNA Test in Cervical Cancer Screening in China
by: Shao-Kai Zhang, et al.
Published: (2020-10-01)

Down-Modulation of Notch1 Expression in Cervical Cancer Is Associated with HPV-Induced Carcinogenesis
by: Li SUN, et al.
Published: (2009-12-01)

Prior cervical cytology and high-risk HPV testing results for 311 patients with invasive cervical adenocarcinoma: a multicenter retrospective study from China’s largest independent operator of pathology laboratories
by: Fengxiang Xie, et al.
Published: (2019-11-01)

Cervical cancer screening using HPV tests on self-samples: attitudes and preferences of women participating in the VALHUDES study
by: Hélène De Pauw, et al.
Published: (2021-08-01)

Clinical validation of high risk HPV DNA testing versus ThinPrep cytology for primary cervical cancer screening
by: Mahmoud El-Morsi Aboul-Fotouh, et al.
Published: (2013-06-01)

Kosovo women’s knowledge and awareness of human papillomavirus (HPV) infection, HPV vaccination, and its relation to cervical cancer
by: Pranvera Zejnullahu Raçi, et al.
Published: (2021-10-01)

Cost-effectiveness of the screen-and-treat strategies using HPV test linked to thermal ablation for cervical cancer prevention in China: a modeling study
by: Xue-Lian Zhao, et al.
Published: (2023-04-01)

Role of HPV16 E1 in cervical carcinogenesis
by: Fern Baedyananda, et al.
Published: (2022-07-01)

A Case for Offering HPV Self-Sampling to Well-Screened Women. Comment on Lesack et al. Willingness to Self-Collect a Sample for HPV-Based Cervical Cancer Screening in a Well-Screened Cohort: HPV FOCAL Survey Results. <i>Curr. Oncol.</i> 2022, <i>29</i>, 3860–3869
by: Roni Kraut, et al.
Published: (2022-07-01)

Improving cervical cancer screening in Mexico: results from the Morelos HPV Study
by: Flores Yvonne, et al.
Published: (2003-01-01)

Primary care experiences in the ‘Let’s test for HPV’ study: a qualitative analysis
by: Susan Garrett, et al.
Published: (2023-01-01)

Association of provider HPV vaccination training with provider assessment of HPV vaccination status and recommendation of HPV vaccination
by: Ikponmwosa Osaghae, et al.
Published: (2022-11-01)